Edema is a term associated with swelling caused due to infection or inflammation of tissues. It occurs when small blood vessels leak fluids, which are stored in surrounding tissues leading to swelling. Edema can be caused due injury, pregnancy, certain heart, kidney or liver disease, and cerebral edema. Medications such as NSAIDS, calcium channel blockers, and corticosteroids used to treat certain diseases can also cause edema. Treatment lies in the understanding of the underlying cause of edema. Mild edema can be cured, without any medication, by raising the affected limb higher than the heart. Severe edema, however, is treated with drugs that help rid the body of excess fluid in the form of urine. These drugs usually include diuretics. Long-term management of edema is required to treat the underlying cause of the ailment. Macular edema is one of the common types of edema observed in diabetic patients. If untreated, it can lead to blindness in diabetic patients. Macular edema is either treated with laser therapy or by medications such as corticosteroids.
Increase in occurrences of cardiac, kidney, and liver diseases is the major factor driving the edema treatment market. Macular edema is higher in diabetes type-2 patients. Due to lifestyle and diet, diabetes and heart disease are very common leading to rise in edema patients. Additionally, continuous research supported by substantial R&D investments by large pharmaceutical companies and advancement in health care technologies are the major factors fueling the growth of the global edema treatment market.
The global edema treatment market can be segmented based on type of edema, treatment type, and region. In terms of type of edema, the market can be classified into macular edema, hereditary angioedema, pulmonary edema, cerebral edema, and generalized edema. Based on treatment type, the market can be segmented into laser therapy and pharmacological therapy. Macular edema is the most common type of edema occurring in type-2 diabetes patients. Hereditary angioedema is the rarest form of edema occurring during childhood. However, symptoms can be observed during adulthood and is caused due to defect in genetic constitution. Pulmonary edema is the abnormal retention of fluid in airspaces between lungs. It is primarily caused due to congestive heart failure due to which the heart is unable to pump fluid out of lungs. Cerebral edema is the accumulation of fluid in the intra or extra cellular spaces of brain. It can be caused due to brain trauma or inflammation occurring due to the breakdown of blood brain barrier or cerebrospinal fluid.
In terms of treatment type, surgical treatment for the treatment of macular edema accounts for a major market share. If medications, diuretics like Lasix and Demadex contribute to the major market share and corticosteroids like triamcinolone etc.
Geographically the global edema treatment market can be segmented into North America, Latin America, Europe, and Asia Pacific, and Middle East & Africa. North America, followed by Europe, is the largest market for edema treatment products owing to the high incidence and prevalence rates of edema caused by heart diseases, diabetes, and other diseases. The market in Asia Pacific is expected to expand at a considerable pace due to developing economies such as India.
Key players and research institutes operating in the global edema treatment market are Genentech Inc. (a member of Roche group), Bayer AG, Europharma Limited (Novartis AG), F. Hoffmann-La Roche Ltd., Stiefel Laboratories Inc., (GlaxoSmithKline Plc.), MayoClinic Pharming Group NV, and Shire plc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.